Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression

Drug Des Devel Ther. 2017 Aug 23:11:2481-2491. doi: 10.2147/DDDT.S134518. eCollection 2017.

Abstract

Paeoniflorin (PF) is an active monoterpene glycoside extracted from Paeonia lactiflora Pall. PF has exhibited antitumor effects in various cancer types. However, the effects of PF in pancreatic cancer are largely unexplored. Here, we showed that PF suppressed growth of pancreatic cancer cell lines Capan-1 and MIAPaCa-2 and profoundly sensitized these cells to X-ray irradiation. Through microarray analysis, we identified HTRA3, a tumor-suppressor candidate gene, as the most increased gene upon PF treatment in Capan-1 cells. Ectopic expression of HTRA3 led to reduced cell proliferation and increased expression of apoptotic protein Bax, suggesting a tumor suppressive role of HTRA3 in pancreatic cancer cells. Together, our results provide a set group of genetic proofs and biological proofs that PF inhibited pancreatic cancer growth by upregulating HTRA3.

Keywords: X-ray irradiation; cancer inhibition; colony formation assay; microar-ray analysis; traditional Chinese medicine.

MeSH terms

  • Adult
  • Aged
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Female
  • Glucosides / isolation & purification
  • Glucosides / pharmacology*
  • Humans
  • Male
  • Microarray Analysis
  • Middle Aged
  • Monoterpenes / isolation & purification
  • Monoterpenes / pharmacology*
  • Paeonia / chemistry*
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology
  • Serine Endopeptidases / genetics*
  • Up-Regulation / drug effects
  • Young Adult

Substances

  • Glucosides
  • Monoterpenes
  • peoniflorin
  • HTRA3 protein, human
  • Serine Endopeptidases